Clinical schizophrenia trials are associated with unique participant retention challenges distinct from other realms of research. Schizophrenia’s complex nature requires attention to detail in trial design and participant management strategies. This checklist will help inform critical decisions regarding trial design to boost participant retention in your next clinical schizophrenia trial.
Preventing & Reducing Participant Dropout in Schizophrenia Clinical Trials
Read more